AHK-Cu (Ala-His-Lys copper complex) engages copper-dependent signaling pathways, acting as a copper-binding tripeptide that modulates extracellular matrix remodeling enzyme activity
Source: However, not all peptides are regulated
Two companies, Phosphagenics Limited and Metabolic Pharmaceuticals Limited, decided to combine their expertise
human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved
Timeline depends on the indication
Improved Mood & Mental Clarity May help reduce symptoms of low mood or brain fog